Federal Official Gazette
OPERATIONAL RESOLUTION ANS No. 3,179, OF OCTOBER 9, 2026
Provides for the establishment of the special Technical Management regime at the operator SAÚDE BRASIL ASSISTÊNCIA MÉDICA LTDA.
OPERATIONAL RESOLUTION ANS No. 3,178, OF OCTOBER 9, 2026
Provides for the order to divest the portfolio of the operator NOVA SAÚDE OPERADORA INTEGRADA DE SAÚDE LTDA.
OPERATIONAL RESOLUTION ANS No. 3,177, OF OCTOBER 9, 2026.
Provides for the establishment of the special Technical Management regime at the operator AMPLITUDE PLANOS DE SAUDE LTDA.
PERSONNEL ORDINANCE ANS No. 297, OF OCTOBER 9, 2026
Art. 1 Ms. Dulcemar Gonçalves Barreto, registered under CPF No. XXX.754.155-XX, is hereby appointed to serve as technical director at the operator SAÚDE BRASIL ASSISTÊNCIA MÉDICA LTDA, ANS registration No. 42.115-4, registered under CNPJ No. 28.633.372/0001-74.
PERSONNEL ORDINANCE ANS No. 296, OF OCTOBER 9, 2026
Art. 1 Ms. Luciana de Lima Barros, registered under CPF No. XXX.549.428-XX, is hereby appointed to serve as technical director at the operator AMPLITUDE PLANOS DE SAUDE LTDA, ANS registration No. 42.385-8, registered under CNPJ No. 43.047.552/0001-68.
ANS news
ANS approves test for diagnosis of lung diseases
The Board of Directors of the National Supplementary Health Agency (ANS) approved, on Oct 9, the update of the list of coverage required of health plans to include bronchoscopy with cryobiopsy, a minimally invasive procedure used to obtain lung tissue samples from patients with suspected interstitial lung disease (ILD).
Outubro Rosa reinforces the importance of preventing breast and cervical cancer
The month is also marked by the expansion of coverage of digital mammography, which will now be guaranteed by health plans without age or gender restriction
Open public consultations
- CP 178. Subject: preliminary recommendations against the incorporation of somatrogon and cabozantinib levomalate. Deadline: from October 7 to October 26, 2026.
Scheduled public hearings
- AP 70. Subject: preliminary recommendations against the incorporation of somatrogon and cabozantinib levomalate, technologies submitted to public consultation 178. Date: Oct 16, from 9:30 a.m. to 12:30 p.m.
Open public calls for input
- The call for input addressed to the ombudsman offices of health plan operators, concerning the effectiveness of service channels and the monitoring provided for in RN No. 623/2024, is open until Oct 20.
Open public calls
There are no open public calls or targeted social participation procedures.
Other news
– No updates.
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.